Thai GPO to produce anti-viral Favipiravir next year

21 Sept 04:24 Key points summarised by AI

Thailand's Government Pharmaceutical Organization (GPO) anticipates producing the anti-viral drug Favipiravir, used for COVID-19 treatment, by early next year.
The GPO is actively developing the drug's formula and conducting rigorous analyses to ensure it meets all necessary specifications.
Initial semi-industrial production will yield 100,000 tablets per unit, with bioequivalence studies on these batches slated for January next year.
Commercial production of Favipiravir is projected to commence in 2022, following successful trials on healthy volunteers and bioavailability assessments.
The GPO is collaborating with the National Science and Technology Development Agency to develop local raw materials for Favipiravir production.

Six injured after car smashes into On Nut shopping mall

Today 22:44 Key points summarised by AI

A 67-year-old woman drove her car through the glass frontage of a Bangkok shopping mall, injuring six people, including a six-year-old girl.
The driver claimed she accidentally pressed the accelerator instead of the brake after being startled, causing the vehicle to surge forward.
She apologized to the victims, promising insurance coverage and additional financial aid, while police continue to gather statements before filing charges.